{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:09:32Z","timestamp":1761059372407},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/ppo.0b013e31826246ac","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T21:05:47Z","timestamp":1343423147000},"page":"343-349","source":"Crossref","is-referenced-by-count":5,"title":["Genetic Testing by Cancer Site"],"prefix":"10.1097","volume":"18","author":[{"given":"Gayun","family":"Chan-Smutko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics.","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1158\/1055-9965.EPI-08-0601","article-title":". Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.","volume":"18","author":"Clague","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R4-10-20210203","first-page":"119","article-title":"Histologic variants of renal cell carcinoma: does tumor type influence outcome Urol Clin North Am.","volume":"39","author":"Deng","year":"2012","journal-title":""},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":". von Hippel-Lindau disease.","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":". Identification of the von Hippel-Lindau disease tumor suppressor gene.","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":". Mutations of the VHL tumour suppressor gene in renal carcinoma.","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"R9-10-20210203","first-page":"2852","article-title":". Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.","volume":"54","author":"Shuin","year":"1994","journal-title":"Cancer Res"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","article-title":"Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons.","volume":"113","author":"Birt","year":"1977","journal-title":"Arch Dermatol"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":". Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome.","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","article-title":". Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome.","volume":"173","author":"Pavlovich","year":"2005","journal-title":"J Urol"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","article-title":". Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome.","volume":"76","author":"Schmidt","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":". Renal tumors in the Birt-Hogg-Dube syndrome.","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R16-10-20210203","first-page":"393","article-title":". Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome.","volume":"11","author":"Zbar","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.200610-1483OC","article-title":". Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dube syndrome.","volume":"175","author":"Toro","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/bjc.2011.463","article-title":". Renal cancer and pneumothorax risk in Birt-Hogg-Dube syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families.","volume":"105","author":"Houweling","year":"2011","journal-title":"Br J Cancer"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11934-010-0156-y","article-title":". Impact of genetics on the diagnosis and treatment of renal cancer.","volume":"12","author":"Singer","year":"2011","journal-title":"Curr Urol Rep"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.2007.054304","article-title":". BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports.","volume":"45","author":"Toro","year":"2008","journal-title":"J Med Genet"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":". Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.onc.1201983","article-title":". Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours.","volume":"17","author":"Fischer","year":"1998","journal-title":"Oncogene"},{"key":"R23-10-20210203","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/1727","article-title":". Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas.","volume":"20","author":"Zhuang","year":"1998","journal-title":"Nat Genet"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/109065701753145547","article-title":". Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.","volume":"5","author":"Lindor","year":"2001","journal-title":"Genet Test"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","article-title":". Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.","volume":"43","author":"Wei","year":"2006","journal-title":"J Med Genet"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","article-title":". Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma.","volume":"48","author":"Gardie","year":"2011","journal-title":"J Med Genet"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":". Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10689-009-9234-z","article-title":". SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis.","volume":"8","author":"Henderson","year":"2009","journal-title":"Fam Cancer"},{"key":"R29-10-20210203","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","article-title":". Germline SDHB mutations and familial renal cell carcinoma.","volume":"100","author":"Ricketts","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/humu.21136","article-title":". Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.","volume":"31","author":"Ricketts","year":"2010","journal-title":"Hum Mutat"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2008.03274.x","article-title":". Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.","volume":"69","author":"Srirangalingam","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e318227e7f4","article-title":". Renal tumors associated with germline SDHB mutation show distinctive morphology.","volume":"35","author":"Gill","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R33-10-20210203","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":". Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.","volume":"54","author":"Roupret","year":"2008","journal-title":"Eur Urol"},{"key":"R34-10-20210203","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","article-title":". Upper urinary tract carcinoma in Lynch syndrome cases.","volume":"185","author":"Crockett","year":"2011","journal-title":"J Urol"},{"key":"R35-10-20210203","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/jmg.2010.076992","article-title":". Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.","volume":"47","author":"van der Post","year":"2010","journal-title":"J Med Genet"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00130404-201207000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:56:39Z","timestamp":1618037799000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130404-201207000-00010"}},"subtitle":["Urinary Tract"],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e31826246ac","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}